VOYA Investment Management
UBX

VOYA Investment Management’s Unity Biotechnology UBX Stock Holding History

VOYA Investment Management’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,649
Closed -$99K – 2900
2021
Q1 		$99K Hold
1,649
– – ﹤0.01% 2672
2020
Q4 		$86K Buy
1,649
+487
+42% +$23.5K ﹤0.01% 2584
2020
Q3 		$40K Hold
1,162
– – ﹤0.01% 2454
2020
Q2 		$101K Sell
1,162
-306
-21% -$22.7K ﹤0.01% 2333
2020
Q1 		$85K Hold
1,468
– – ﹤0.01% 2384
2019
Q4 		$106K Buy
1,468
+283
+24% +$20K ﹤0.01% 2532
2019
Q3 		$72K Hold
1,185
– – ﹤0.01% 2466
2019
Q2 		$113K Buy
1,185
+161
+16% +$13.7K ﹤0.01% 2441
2019
Q1 		$83K Hold
1,024
– – ﹤0.01% 2459
2018
Q4 		$166K Buy
+1,024
New +$136K ﹤0.01% 2275

Other funds holding UBX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VOYA Investment Management's UBX Position: Q2 2021 in Review

VOYA Investment Management sold out of Unity Biotechnology (UBX) in Q2 2021, closing a stake of 1,649 shares — an estimated $99K sold.

VOYA Investment Management first reported a position in UBX in Q4 2018 and held it in 10 quarters. The position peaked at $166K in Q4 2018. 98 funds tracked by Wall St. Rank hold UBX as of Q2 2021.

  • VOYA Investment Management reported no remaining Unity Biotechnology position as of Q2 2021 after selling out during the quarter.
  • VOYA Investment Management sold 1,649 Unity Biotechnology shares in Q2 2021, an estimated $99K.
  • VOYA Investment Management first reported a position in Unity Biotechnology in Q4 2018 and held it in 10 quarters.
  • VOYA Investment Management's Unity Biotechnology position peaked at $166K in Q4 2018.
  • 98 funds tracked by Wall St. Rank held Unity Biotechnology as of Q2 2021.

Based on VOYA Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.